Nuciferine, an active ingredient derived from lotus leaf, lights up the way for the potential treatment of obesity and obesity-related diseases

This publication has 127 references indexed in Scilit:

• Nuciferine Prevents Hepatic Steatosis and Injury Induced by a High-Fat Diet in Hamsters
  PLOS ONE, 2013
• Dyslipidemia in Obesity: Mechanisms and Potential Targets
  Nutrients, 2013
• Structure, function and diversity of the healthy human microbiome
  Nature, 2012
• Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment
  EMBO Molecular Medicine, 2011
• Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
• Obesity and Acute Lung Injury
  Clinics in Chest Medicine, 2009
• (1R, 3S)-(−)-Trans-PAT: A novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity
  European Journal of Pharmacology, 2009
• PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis
  Proceedings of the National Academy of Sciences, 2008
• Obesity and Obstructive Sleep Apnea: Pathogenic Mechanisms and Therapeutic Approaches
  Proceedings of the American Thoracic Society, 2008
• Obesity induces a phenotypic switch in adipose tissue macrophage polarization
  Journal of Clinical Investigation, 2007